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Oxide in RAW 264.7 Mouse Macrophages
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Prunella vulgaris has been used therapeutically for inflammation-related conditions for centuries, but
systematic studies of its anti-inflammatory activity are lacking and no specific active components
have been identified. In this study, water and ethanol extracts of four P. vulgaris accessions were
applied to RAW 264.7 mouse macrophages, and the ethanol extracts significantly inhibited
lipopolysaccharide (LPS)-stimulated prostaglandin E2 (PGE2) and nitric oxide (NO) production at
30 μg/mL without affecting cell viability. Extracts from different accessions of P. vulgaris were
screened for anti-inflammatory activity to identify accessions with the greatest activity. The inhibition
of PGE2 and NO production by selected extracts was dose-dependent, with significant effects seen
at concentrations as low as 10 μg/mL. Fractionation of ethanol extracts from the active accession,
Ames 27664, suggested fractions 3 and 5 as possible major contributors to the overall activity.
Rosmarinic acid (RA) content in P. vulgaris was found to independently inhibit inflammatory
response, but it only partially explained the extracts’ activity. LPS-induced cyclooxygenase-2
(COX-2) and nitric oxide synthase (iNOS) protein expression were both attenuated by P. vulgaris
ethanol extracts, whereas RA inhibited only COX-2 expression.
KEYWORDS: Prunella vulgaris; extracts; fractionation; prostaglandin E2; nitric oxide; rosmarinic acid;
anti-inflammatory
INTRODUCTION
Prunella vulgaris (Lamiaceae), commonly called self-heal, is a
perennial herb widely distributed in Asia and Europe. In Europe,
P. vulgaris has been a popular traditional remedy since the 17th
century for several medical conditions including mild fever, sore
throat, and external wound healing (1). In China, P. vulgaris is
called “Xia Ku Cao” and has a long history in therapeutic use as
an antipyretic and, more recently, for antikeratitis purposes (2).
In South Korea, P. vulgaris is applied to patients with goiter,
dermatitis, and skin allergy (3). Despite its wide use for health
purposes, only a few scientific studies have addressed the health-
promoting claims of P. vulgaris. Aqueous extracts of P. vulgaris,
rich in carbohydrates, were reported to have anticarcino-
genic, counter-UV damage, immune-regulatory, and antiviral
effects (4-6). In addition, increasing evidence suggests that
extracts prepared with organic solvents, such as ethanol and
methanol, possess antiestrogenic, anti-inflammatory, and anti-
oxidative properties (7-9).
Although most of the bioactivities seen in P. vulgaris water
extracts are attributed to polysaccharide compounds, no specific
component in these extracts has been associated with anti-
inflammatory activity (6). On the other hand, a polyphenol-rich
aqueous ethanolic extract (30% v/v) contains two known con-
stituents with anti-inflammatory activity, namely, rosmarinic
acid (RA) and ursolic acid (UA) (8, 10). Information regarding
the relative abundance of possible anti-inflammatory compounds
in different populations of P. vulgaris is not available, and direct
comparison of activity among different accessions has not been
reported.
Inflammation is critical in recruiting immune cells and mole-
cules to the site of infection for defense.However, various kinds of
tissue damage and pathological consequences ensue when “sterile
inflammation”, such as obesity and self-immune diseases, occurs
or infection-induced inflammation becomes chronic. Among
participating cells, macrophages play a central role in organizing
the release of inflammation mediators, including prostaglandin
E2 (PGE2), nitric oxide (NO), and cytokines that promote host
protection, as well as causing pathological consequences such as
tissue edema and abnormal histological change (8,11). TheRAW
*Author to whom correspondence should be addressed [telephone
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264.7 mouse macrophage cell line is widely used for studies of
inflammation, due to its reproducible response to lipopolysac-
charide (LPS), mediated by toll-like receptor 4 (TLR4) (12). Our
previous research on Hypericum and Echinacea species success-
fully employed this model to study the effects of these botanical
materials on cyclooxygenase-2 (COX-2) regulated PGE2 produc-
tion and upstream intracellular events (13, 14). Other research
with these cells indicates a well-defined nitric oxide induction by
LPS through inducible nitric oxide synthase (iNOS) (15). There-
fore, we used this model to investigate the effect of P. vulgaris
extracts on these two major inflammatory mediators.
The main purpose of the current study was to compare anti-
inflammatory activity of water and ethanol extracts ofP. vulgaris
in LPS-stimulated RAW 264.7 mouse macrophages and to assess
any differences in activity among different P. vulgaris accessions.
Fractionation of active extracts allowed us to explore possible
bioactive compounds. At the same time, parallel comparison of
pure compounds and extract activities revealed the contribution
of selected compounds.
MATERIALS AND METHODS
PlantMaterials.Vegetative samples ofP. vulgariswere acquired from
the North Central Regional Plant Introduction Station (NCRPIS) of the
U.S. Department of Agriculture, Agricultural Research Service (USDA/
ARS), Ames, IA. This study included accessions Ames 27664, 27665, and
27666 from North Carolina, Ames 27748 and 28436 (PI 656842) from
Missouri, and Ames 28353 (PI 656839), 28354 (PI 656840), 28355, 28356,
28357 (PI 656841), 28358, and 28359 from Iowa. Further detailed
information about the origins of these accessions is available from the
Germplasm Resources Information Network (GRIN) database at http://
www.ars-grin.gov/npgs/acc/acc_queries.html.
Seeds from original samples of all these accessions were germinated
at 25 C in Petri plates and then transferred to greenhouse flats held at 20-
25 C. In April 2006, seedlings of Ames 27664, 27665, 27666, and 27748
were transplanted to the field at 2 months of age, and each individual
accession was isolated within control-pollination cages. In October 2007,
above-ground portions of these accessions were harvested and air-dried at
∼40 C for 1 week. Dried samples were then ground in a Wiley mill and
stored at -20 C under nitrogen until extraction.
In May 2007, 2-month-old seedlings of the remaining accessions were
transplanted to the same field with the same isolation procedure. In July
2008, all accessions in the field, except forAmes 27666,were harvested, air-
dried, ground, and stored, as noted above.
The taxonomic identity of each accession was confirmed at the time of
flowering. Seed samples for each accession are conserved and distributed
by theNCRPIS, and corresponding voucher specimens are held at theAda
Hayden Herbarium, Iowa State University.
Sterilization Technique.All glasswarewas heated at 200 C for 2 h to
destroy endotoxin,whereas other supplieswere purchased sterile.Random
samples of supernatant and cell pellet were chosen from cell culture in
selected experiments for mycoplasma screening with a MycoProbe myco-
plasma detection kit (R&D Systems, Minneapolis, MN), and no contam-
ination was found. Water, ethanol, and DMSO solvents, along with
extraction and fractionation products, were tested for endotoxin by using
a Lymulus Amebocyte Lysate Test (Bio Whittaker, Walkersville,
MD) (14). The endotoxin levels ranged from undetectable to 0.000658
EU/mL for all extracts and ethanol fractions, well below the 5 EU/mL
threshold for significant stimulation of RAW 264.7 macrophages (13).
Endotoxin levels of water fractions, ranging from 0.0001 to 0.0044 EU/
mL, were higher than those of extracts and ethanol fractions.
Rosmarinic Acid and Ursolic Acid.Rosmarinic acid and ursolic acid
at 90-100 and 95% purity, respectively (as graded by the manufacturer,
Fisher Scientific, Hanover Park, IL), were dissolved in dimethyl sulfoxide
(DMSO) to 100 and 50 mM stock concentration, respectively, and stored
at -20 C.
Extraction and Fractionation of P. vulgaris. Ethanol Extraction.
Six grams of driedP. vulgaris ground sample was extractedwith 500mL of
95% ethanol via Soxhlet for 6 h. The extract was filtered and then dried by
rotary evaporation at<40 C followed by lyophilization. The extract was
then dissolved in theminimal amount ofDMSO that completely dissolved
the residue and stored at -20 C.
Water extraction. Six grams of dried P. vulgaris ground sample was
extracted with 100 mL of boiling endotoxin-free water. The plant material
was steeped with stirring for 1 h and then filtered through a G6 glass fiber
circle (Fisher Scientific, Hanover Park, IL) in a Buchner funnel. The
filtrate was centrifuged at 10000g for 20 min to remove additional
particulates. Then, the extract was lyophilized, weighed, and redissolved
with theminimal volumeof endotoxin-freewater that dissolved the residue
and stored at -20 C.
Size Exclusion Chromatography Fractionation of the Water Extract.
Two grams of dry P. vulgarisAmes 27664 water extract residue, dissolved
in 10mLof endotoxin-freewater,was loadedonto a 2.5 75 cmSephacryl
100HR column. Elutionwaswith endotoxin-freewater, and the eluentwas
collected in 10 mL individual fractions over the following 72 h until a
combined volume of 2 L was recovered. The absorbance at 210 nm was
measured for all tubes. Nine peaks were reserved, according towhich these
fractions were pooled into eight fractions and concentrated by lyophiliza-
tion, after the last two peaks had pooled in the same fraction due to their
low yield. The residues after lyophilization were then completely dissolved
in the same volume of water, and all fractions were stored at -20 C.
Semipreparative HPLC Fractionation of the Ethanol Extract. One
hundred milligrams of dry P. vulgarisAmes 27664 ethanol extract residue,
dissolved in 0.5 mL of 60% ethanol, was loaded onto an YMC-pack
ODS-AM 250  10 mm C18 column (YMC, Kyoto, Japan). The HPLC
system used was a Beckman-Coulter System Gold with a 126 solvent
module, a model 508 autosampler, and a model 168 detector. Solvents
were endotoxin-free water containing 0.1% acetic acid as A and acetoni-
trile as B, following the gradient shown in Table 1. On the basis of the
absorbance peaks at 210 nm, 2 mL aliquots of fractions from the ethanol
extract were pooled into seven fractions, which were concentrated by
lyophilization and later dissolved with the same amount of DMSO for
storage at -20 C.
Cell Culture and Treatment with Plant Materials. RAW 264.7
mouse macrophage cells (American Type Culture Collection, Manassas,
VA) were cultured as described by Hammer et al. (13) in high-glucose
Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 10%
fetal bovine serum, 10% sodium bicarbonate, and 100 IU/mL penicillin/
streptomycin (all from Invitrogen, Carlsbad, CA). The cells were incu-
bated at 37 C under 5% CO2 and grew to 80% confluency before
passaging or plating. Cells were plated in 24- or 48-well plates or on Petri
dishes (Corning, Lowell, MA) for treatment as described by Hammer et
al. (13).When the plated cells reached 80% (for 8 h treatment) or 60% (for
24 h treatment) confluency, the stock of P. vulgaris extracts and fractions,
or pure compounds, was diluted to 1000 treatment concentration with
vehicle solvent and then added to media at 0.1%. Treatments in 500 μL of
media were applied to macrophages in 24-well plates for PGE2 and NO
assay. For cytotoxicity assay, 300 μL of treatment was applied to the 48-
well plates. For Western blotting, treatments in 10 mL of media were
added to the Petri dishes. Except for the cytotoxicity assay, which was
conducted without induction, each treatment was administered with and
without stimulation by 1 μg/mL LPS (Escherichia coli 02B:B6) (Sigma, St.
Louis, MO). Three replicates were included on three individual plates.
Aside frommedia control andDMSOvehicle control at 0.1%v/v, a 10μM
(100 μM for Western blotting) quercetin (Sigma) treatment was also
included as a positive control in each experiment to validate each assay
because of its proven anti-inflammatory activity aswell as its presence inP.
vulgaris ethanol extract at a trace amount (16). Two additional strategies
were also attempted for PGE2 assay, one using a 30min pretreatmentwith
extracts before LPS induction and the other using a 2 h LPS induction
before administration of plant extracts.
Table 1. Solvent Gradient for Ethanol Extract Fractionationa
duration
solvent 30 min 10 min 40 min 10 min 40 min 10 min
A 90-70% 70-60% 60-20% 20-0% 0% 0-90%
B 10-30% 30-40% 40-80% 80-100% 100% 100-10%
a Solvent A is water with 0.1% acetic acid. Solvent B is acetonitrile.
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Cell Viability Measurement. Cytotoxicity was assayed on all ex-
tracts, fractions, and pure compounds following a protocol modified from
that of Schmitt et al. (17). Ursolic acid, a known cytotoxic constituent of
P. vulgaris plant material that accounts for 0.05-0.2% of dry matter (18),
was used as the positive control at 10 and 30 μM. The maximal treatment
dose used in the bioactivity assays was applied to cells for 24 h in 48-well
plates before being replaced by 200 μL of fresh media and 30 μL of
Celltiter96 Aqueous One Solution Cell Proliferation Assay solution
(Promega, Madison, WI). After a 195 min incubation, 200 μL of
metabolized dye product was transferred from each well to a 96-well
plate, and absorbance was read by a plate reader at 562 nm. Percentages of
viability compared to media þ DMSO control were determined for all
treatments.
Prostaglandin E2 and Nitric Oxide Measurement. Treatment
lasted 8 h for PGE2 assay and 24 h for NO assay before all supernatant
in each well was collected on ice for future assays (19). After collection, the
supernatant was kept at -80 C before the PGE2 assay was conducted.
Samples were diluted (1:15) and analyzed with Biotrek PGE2 enzyme
immune assay (EIA) (GE Healthcare, Piscataway, NJ) according to the
manufacturer’s protocol. PGE2 concentrations in the supernatant samples
were determined by comparison with a standard curve.
For the NOassay, the supernatant was collected after 24 h of treatment
and stored at 4 Cbefore analysis.Griess reagent (Promega) was employed
to indirectly measure NO production in cell culture by measuring nitrite
concentration (20). Fifty microliters of supernatant sample or a series of
standards was mixed with 50 μL of sulfanilamide solution (1% sulfanila-
mide in 5%phosphoric acid) in a 96-well plate for a 7 min incubation on a
rocker in the dark. Then 50 μL of 1% N-1-naphthylethylenediamine
dihydrochloride (dissolved in water) was added followed by another 7min
incubation. Optical absorbance was measured at 562 nm, and nitrite
concentrations in supernatant samples were obtained with reference to a
standard curve.
Quantification of Rosmarinic Acid and Ursolic Acid. Identifica-
tion and quantification of rosmarinic acid in P. vulgaris extract were
performedwith aBeckmanCoulter SystemGoldNouveauHPLCcoupled
to Beckman System Gold 168 UV-vis diode array detector (PDA)
controlled by 32karat software (version 5.0) with a Supelcosil LC-18
(250 4.6 mm, 5 μm) column (Sigma). The solvent system was 5% acetic
acid in water as A and 25% acetonitrile plus 5% acetic acid as B at a flow
rate of 1.0 mL/min. The following gradient was used: 40% B/60% A to
70%B/30%A for 10min, then to 100%B for 1min, and finally to 40%B/
60% A for 12 min. Rosmarinic acid concentrations were determined with
UV absorbance at 326 nm in comparison with standard compound
(Cayman Chemicals, Ann Arbor, MI). A reverse phase analytical
YMC-pack ODS C18 (250  4.6 mm, 5 μm) column (YMC) was used
under room temperature for ursolic acid identification and qualification.
Themobile phase used for ursolic acid analysiswas 1.25%phosphoric acid
and acetonitrile at 0.5 mL/min. The gradient used was 15% acetonitrile at
0min, increased to 84%over 15min, held for 40min, and finally decreased
to 15% at 65 min. Ursolic acid concentrations were determined with UV
absorbance at 210 nm in comparison with standard compound (Sigma).
Enzyme Expression Measurement. For COX-1 and COX-2 mea-
surement, cell lysate was acquired after an 8 h treatment as previously
described (21), followed by SDS-PAGE separation and ECL detection,
whereas iNOS samples were collected after a 24 h treatment. Mouse
monoclonal primary antibodies against COX-1 (sc-19998), iNOS (sc-
7271), COX-2 (sc-19999), and R-tubulin (sc-8035) (Santa Cruz Biotech-
nology, Santa Cruz, CA) were diluted to 1:1000, 1:600, 1:1200, and 1:2000
individually in 5% powdered milk in Tris buffer saline with 0.1% Tween-
20. Arbitrary densities after normalization of four replicate blots were
archived by Quantity One program (Bio-Rad, Hercules, CA).
Statistical Analysis. For the cytotoxicity assay, three measurements
of each treatment were collected in each of three plates and averaged
within plates. PGE2 and NO activities for treatments in each experiment
were measured on three plates. For other experiments, a randomized
complete block ANOVA was conducted on log-transformed PGE2
concentration, NO concentration, and cell viability values, with the plate
as fixed block to identify treatment effect. For each assay, a control
treatment was included for media and vehicle (water or DMSO) with and
withoutLPS stimulation.All treatments and thewater vehicle controlwere
compared against the media þ DMSO vehicle control, and the averages
and standard errors as percentage of vehicle control for each treatment
were reported. Multiple comparisons among treatments for Western
blotting data were conducted with a pairwise Student t test after a
significant difference was found among treatments by ANOVA (SAS
9.0 SAS Institute Inc., Cary, NC).
RESULTS
Cytotoxicity of P. vulgaris Extracts and Fractions on RAW
264.7 Macrophages. All water and ethanol extracts, from all
accessions included in this study, were screened for cytotoxicity
at 30 μg/mL, the maximal concentration used in this study. In
addition, fractions from certain extracts were also screened at the
concentrations used in activity assays. Cytotoxicity was not
observed with RAW 264.7 macrophages treated with any extract
or fraction, whereas the ursolic acid, as a positive cytotoxic
control, caused 50% reduction of cell viability (p < 0.01) at
30 μM (150-fold the concentration found in P. vulgaris extracts).
Inhibition of LPS-Induced PGE2 and NO Production by
P. vulgaris Extracts. Both water and ethanol extracts from all
four 2007-harvested P. vulgaris accessions (Ames 27664, 27665,
27666, and 27748) were included in the initial screening for
inhibition of PGE2 and NO production at 30 μg/mL concentra-
tion, the highest concentration achievable with all extracts. As
shown in Figure 1, ethanol extracts from all accessions except
Ames 27748 significantly inhibited LPS-induced PGE2 produc-
tion as compared to the DMSO vehicle control treatment. On the
contrary, water extracts did not exert significant inhibition of
PGE2 production at the same concentration. Ethanol extracts
from Ames 27664, 27665, and 27666 inhibited LPS-stimulated
PGE2 by 36, 23, and 25%, respectively. LPS-induced NO
production was significantly inhibited by all extracts except for
the water extract from Ames 27748. Water extracts from Ames
27664, 27665, and 27666 significantly decreased NO levels by
10-15%, which were less potent than their ethanol-extracted
counterparts, which inhibited NO by 24-26%. Although Ames
27748 water extract had no significant effect on NO production,
ethanol extract from this accession decreased NO by 69% as
compared to vehicle control. Different treatment strategies,
including pretreatment with extracts or LPS, as described under
Materials andMethods, did not change the observed effect (data
not shown). No change in either baseline PGE2 or NO produc-
tion was seen when RAW 264.7 macrophages were treated with
extracts without LPS stimulation (data not shown).
Difference of Inhibition Potency among Ethanol Extracts from
Different P. vulgaris Accessions. Ethanol extracts from all acces-
sions harvested in 2008 were applied to cell culture at 30 μg/mL
concentration. As shown inTable 2, in comparison to the DMSO
vehicle control, accessions Ames 27664, 28358, 28357, and 28355
significantly reduced LPS-stimulated PGE2 production, and all
extracts significantly decreased LPS-induced NO. Relatively
greater overall inhibition of LPS-induced PGE2 and NO release
was observed on extracts from accessions Ames 27664, 28358,
28357, and 28355.
Dose-Response Relationship of the Inhibition on PGE2 and NO
Production by Selected P. vulgaris Ethanol Extracts. Because
the ethanol extract from accession Ames 27664 harvested in
2007 had the greatest inhibitory activity on LPS-induced PGE2
and NO release among all accessions from both years tested,
the dose-response relationship for its activity was evaluated.
Four different doses were applied to cells: 30, 20, 15, and 7.5 μg/
mL. The resulting effect on LPS-induced inflammatory res-
ponse is shown in Figure 2, indicating the inhibition on LPS-
induced PGE2 and NO production followed a dose-dependent
pattern with stronger inhibition accompanied at higher concen-
tration.
10582 J. Agric. Food Chem., Vol. 57, No. 22, 2009 Huang et al.
Ethanol extracts of accessions Ames 27664, 28358, and 28355
from the 2008 harvest were also applied to cell culture at serial
doses to establish the dose-response relationship. For each
extract, administration concentrations were 30, 10, and 5 μg/
mL. As shown in Figure 3, all three extracts demonstrated a dose-
dependent activity in reducing PGE2 and NO production,
although the reduction was not statistically significant at lower
concentrations. Consistent with the initial screening, these ex-
tracts significantly inhibited both LPS-induced PGE2 and NO
release at the starting concentration of 30 μg/mL. When the dose
was decreased, the inhibition was weakened, as only accessions
Ames 27664 and 28355 showed significant effect at 10 μg/mL on
PGE2 and NO production, respectively.
Contribution of Fractions to the PGE2 and NO Inhibition by
P. vulgaris Extract. Both water and ethanol extracts from
accession Ames 27664 (2007 harvest) were fractionated and
screened for activity. As panels A and B of Figure 4 show, at
the concentrations proportional to their yield from the extract,
fractions 1, 3, and 5 significantly inhibited LPS-induced PGE2
production, whereasNO level was reduced by all fractions.When
the dosewas normalized to 20μg/mL, only fraction 3 significantly
reduced both PGE2 and NO production by 28 and 8%, respec-
tively. Fraction 5 also significantly alleviatedNO release by 11%,
as indicated byFigure 4C,D. In contrast, fractions from the water
extract of the same plant material did not exert any significant
inhibition on LPS-stimulated PGE2 or NO release (data not
shown). The baseline PGE2 and NO productions without LPS
induction were significantly elevated compared to control and
other treatments. To clarify whether the ethanol extract had
Figure 1. RAW 264.7 macrophages were treated with water and ethanol extracts from four accessions of P. vulgaris harvested in 2007 at 30 μg/mL with or
without 1 μg/mL LPS induction. The resulting LPS-stimulated PGE2 (A) and NO productions (B) are presented as percentage of vehicle control mediaþ
DMSO treatment in mean ( SEM (N = 3). The 100% levels of PGE2 and NO productions were 3.94 ( 0.37 ng/mL and 19.4 ( 1.21 μM, respectively.
Statistically significant differences compared to the vehicle control are marked with asterisks (/, p < 0.05; //, p < 0.01). Quercetin was used as a positive
control at 10 μM concentration. No difference was found in PGE2 and NO production among treatments without LPS induction, which is not shown.
Table 2. Inhibition of PGE2 and NO Production by Ethanol Extracts from
Accessions in 2008 Harvesta
NCRPIS
accession (Ames no.)
% PGE2
inhibition (( SEM)
% NO inhibition
(( SEM)
27664 18 ( 3* 19 ( 3**
28353 13( 4 27 ( 1**
28354 12( 3 18 ( 5**
28355 26 ( 3** 24 ( 1**
28356 11( 8 27 ( 3**
28357 16 ( 4* 34 ( 6**
28358 19 ( 6* 33 ( 3**
28359 11( 1 27 ( 1**
28436 11( 8 27 ( 7**
aPercentage inhibition of LPS-induced PGE2 and NO released by RAW 264.7
macrophages compared to media þ DMSO vehicle control is shown as mean (
SEM (%). Significant reduction is highlighted with bold numbers as well as labeled
with asterisks (*, p < 0.05; **, p < 0.01; N = 3).
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active components that were also present in the water extract, a
sequential extraction with water was performed on Ames 27664
ethanol extract. The re-extracted product was tested for activity
against LPS-induced NO release along with the ethanol extract.
Although the ethanol extract significantly reduced NO produc-
tionby 22%, the sequential ethanol thenwater extractionproduct
had no activity compared to the vehicle control.
Rosmarinic Acid and Ursolic Acid in P. vulgaris Ethanol
Extracts and Fractions. Because RA is a proven anti-inflamma-
tory and antioxidative polyphenol carboxylic component of
P. vulgaris (8, 22), its abundance was quantified (Table 3. The
overallmean(SERAcontent for all accessionswas 2.1( 0.3μM
in 30 μg/mL extract. Extracts from Ames 27748 and 27664 (2007
and 2008 harvests) contained significantly more RA than did the
others, whereas those fromAmes 28356 and 28359 had the lowest
RA concentrations. Fractions from Ames 27664 ethanol extracts
also contained rosmarinic acid (Table 4). Fractions 5 and 7 had
significantly more RA at concentrations in proportion to their
yield. When normalized to the same fraction concentration of
20 μg/mL, only fraction 5 contained a higher amount of RA. UA
concentration is very low in P. vulgaris ethanol extract as we
detected 0.2 μMin 30 μg/mLAmes 27664 extract and none in any
of its fractions.
Inhibition of PGE2and NO by Rosmarinic Acid in P. vulgaris
Ethanol Extracts. The effects of pure RA, ethanol extracts, and
extracts enrichedwithRAwere compared onLPS-induced PGE2
and NO production. Pure RA compound was applied to cell
culture at 2.67 μM, the concentration found in Ames 27664
ethanol extract from the 2007 harvest. The enrichment dose was
also 2.67 μM in order to allow us to assess whether an additive or
synergetic effect existed betweenRAandother components of the
extracts. As displayed in Figure 5, RA alone significantly inhib-
ited bothLPS-inducedPGE2andNOproductionby 15and 17%,
respectively. Ames 27664 ethanol extract had a significantly
stronger inhibition of 31 and 20%, whereas the “RA-enriched”
ethanol extract from the same accession inhibited the two
inflammation mediators by as much as 39 and 29%. RA enrich-
ment significantly enhanced the potency of the extract in an
additive fashion; no interaction between RA and whole extracts
was observed (p = 0.85) when analyzed with a 2  4 two-way
ANOVA (RA effect and extracts effect).
COX-2 and iNOS Expression with P. vulgaris Ethanol Extracts
and Rosmarinic Acid Treatment. After 8 h of treatment with
ethanol extracts fromAmes 27664 harvested in 2007 and 2008, as
well as with pure RA, COX-2 expression in RAW 264.7 macro-
phages was assayed by Western blot. As shown in Figure 6,
P. vulgaris ethanol extracts and pure RA significantly suppressed
LPS-stimulated COX-2 expression as compared to media þ
DMSO vehicle control. There was no significant difference in
treatment effect onCOX-2 expression except that the 2007 extract
Figure 2. Ethanol extracts from accessions Ames 27664 (2007 harvest) were applied to RAW 264.7 macrophages at 7.5, 15, 20, and 30 μg/mL with or
without 1μg/mL LPS induction. PGE2 (A) and NO (B) levels as percentage of mediaþDMSO vehicle control are shown asmean(SEM (N = 3). The 100%
levels of PGE2 and NO were 4.84( 0.30 ng/mL and 10.5( 0.97 μM, respectively. Statistically significant differences compared to the vehicle control are
marked with asterisks (/, p < 0.05; //, p < 0.01). Quercetin was used as a positive control at 10 μM concentration. No difference was found in PGE2 and NO
production without LPS stimulation among treatments, which is not shown.
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was more effective than those from 2008. With regard to iNOS
expression, significant inhibition after 24 h of induction was only
observed with extracts but not RA treatment, and the quercetin
control was more active than the other treatments. At the same
time, constitutive expression ofCOX-1was not affected by any of
the treatments.
DISCUSSION
Prunella vulgaris has been used as traditional and alternative
therapy for minor acute inflammation and chronic inflammatory
diseases for over two decades (1), but systematic scientific proof
of its efficacy is limited. Whereas the majority of earlier research
focused on the immune-regulatory, skin UV-damage protective,
and antimicrobial effects of P. vulgaris water extracts (4,23), our
study showed that ethanol extracts from selected accessions of
P. vulgaris significantly inhibited production of LPS-induced
inflammatory mediators PGE2 and NO by RAW 264.7 mouse
macrophages. This is in accordance with reports on anti-inflam-
matory activity of P. vulgaris ethanol extracts (3, 8, 24), whereas
the water extract was attributed with putative immunostimula-
tory activity (4). However, to our knowledge, this is the first study
to systematically demonstrate that P. vulgaris ethanol extracts
from various accessions dose-dependently inhibited LPS-induced
PGE2 and NO production without cytotoxicity. The water
extracts from the same accessions had no effect on PGE2
production, but exerted mild inhibition on NO production. A
past study of the water extracts used in the present research
demonstrated the presence of abundant polysaccharides, asso-
ciated with antiviral activity (5). To unveil whether polysacchar-
ide was a common active component in both water and ethanol
extracts, we tested the effect of aqueous re-extraction of the most
active Ames 27664 ethanol extract against LPS-induced PGE2
and NO release and compared it to the original ethanol extract.
This sequential extract did not significantly reduce PGE2 pro-
duction, suggesting that polysaccharides did not play a role in the
anti-inflammatory activity of the ethanol extract. We did not
further study thewater extracts due to their very limited activity in
the study. Although most assayed ethanol extracts were able to
attenuate both the LPS-induced production of PGE2 and NO,
their potency on these two major inflammation mediators
varied among accessions. This difference suggests that active
compound(s) were produced unequally in these plant materials,
even in the same accession from different harvests, and highlights
the importance of chemical profile in anti-inflammatory activity.
So far, accession Ames 27664 exerted the greatest inhibition on
LPS-induced PGE2 and NO. In general, P. vulgaris ethanol
extracts inhibited LPS-induced PGE2 and NO by 20-40% at
concentrations as high as 20-30 μg/mL, which was a lower
specific activity than we have seen in parallel studies of Hyper-
icum (13) and Echinacea (14).
Figure 3. Ethanol extracts from accessions Ames 27664, 28358, and 28355 (2008 harvest) were applied to RAW 264.7 cells at 5, 10, and 30 μg/mL with or
without 1 μg/mL LPS induction. PGE2 (A) and NO (B) production as percentage of mediaþ DMSO vehicle control is shown as mean( SEM (N = 3). The
100% levels of PGE2 andNOwere 3.86( 0.40 ng/mL and 7.7( 0.98μM, respectively. Statistically significant differences compared to the vehicle control are
marked with asterisks (/, p < 0.05; //, p < 0.01). Quercetin was used as a positive control at 10 μM concentration. No difference was found in PGE2 and NO
production without LPS stimulation among treatments, which is not shown.
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Production of PGE2 and NO by macrophages upon LPS
induction was reported to be mediated by the toll-like recep-
tor 4 (TLR-4) and subsequent nuclear factor-κB (NF-κB)
downstream activation, which results in expression of COX-2
and iNOS (25). However, we saw somewhat different patterns
between the effects of P. vulgaris extracts on PGE2 and NO
production. For instance, Ames 27748 ethanol extract had no
significant effect on PGE2 but imposed strong inhibition on NO
production. This could result from differential effects on tran-
scriptional or/and post-transcriptional regulation of COX-2 and
iNOS, which are worthy of future investigation.
Ethanol extract from Ames 27664 was fractionated into
seven fractions with the intent of identifying possible active
components. Three fractions demonstrated significant inhibi-
tion of LPS-induced PGE2 and NO production at concentra-
tions in proportion to their yield from the extract. Among
them, fractions 3 and 5, respectively, had significant effect on
Figure 4. Seven fractions from ethanol extract of accession Ames 27664 (2007 harvest) were applied to RAW 264.7 macrophages at concentrations in
proportion to their yield (A, B) or at a normalized concentration of 20 μg/mL (C, D) with or without 1 μg/mL LPS induction. Resulting PGE2 (A, C) and NO
(B,D) productions are shown as percentage of mediaþDMSO vehicle control as mean( SEM (N = 3). The 100% levels of PGE2 and NOwere 3.89( 0.42
(A) and 4.32( 0.31 (C) ng/mL and 14.9( 0.84 (B) and 19.8( 1.19 (1D) μM, respectively. Statistically significant differences are marked with asterisks
(/, p < 0.05; //, p < 0.01). Quercetin was used as a positive control at 10 μM concentration. No difference was found in PGE2 and NO production without LPS
stimulation among treatments, which is not shown.
Table 3. Abundance of Rosmarinic Acid in Ethanol Extracts from Different
P. vulgaris Accessionsa
NCRPIS accession
(Ames no.)
RA content in
30 μg/mL extracts (μM) (mean ( SEM)
27664 (2007 harvest) 2.7( 0.1*
27664 3.2( 0.2**
27665 2.0( 0.1
27748 3.7( 0.2**
28353 1.6( 0.1
28354 1.8( 0.2
28355 1.8( 0.1
28356 1.5( 0.1
28358 1.6( 0.2
28359 1.4( 0.1
28436 1.7( 0.2
aHPLC was used to quantitate rosmarinic content in selected ethanol extracts
from several P. vulgaris accessions. Accessions in which RA content is significantly
higher than the overall average are labeled with asterisks (*, p < 0.05; **, p < 0.01;
N = 9 or 10).
Table 4. Abundance of Rosmarinic Acid in Fractions from Ames 27664
P. vulgaris Ethanol Extracta
RA content in the fractions (μM)
fraction
in fractions at concentrations
proportional to yield
in 20 μg/mL
fractions
1 0.5( 0.1 in 27.0 μg/mL 0.4( 0.1
2 1.3 ( 0.2 in 51.5 μg/mL 0.5( 0.1
3 0.9( 0.1 in 33.5 μg/mL 0.5( 0.2
4 0.8( 0.2 in 30.0 μg/mL 0.5( 0.1
5 5.2 ( 0.3** in 94.5 μg/mL 1.1( 0.2**
6 0.8( 0.2 in 30.0 μg/mL 0.5( 0.1
7 1.6( 0.3* in 59.0 μg/mL 0.5( 0.1
aHPLC was used to quantitate rosmarinic content in all fractions from Ames
27664 P. vulgaris ethanol extract (2007 harvest). RA amount in fractions at
concentrations in proportion to their yield and at 20 μg/mL are both shown. Fractions
in which RA content is significantly higher than the overall average are labeled with
asterisks (*, p < 0.05; **, p < 0.01; N = 9).
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NO when treatment concentration was normalized to 20 μg/
mL, whereas only fraction 3 significantly attenuated PGE2
level at this concentration. These observations revealed that
active components of the ethanol extract were distributed in
more than one fraction and act through different pathways.
Considering that fraction 3 was the only fraction that signifi-
cantly decreased both the PGE2 and NO productions at 20 μg/
mL, it was expected to be relatively more abundant in
active compounds or contain the major active constituent. On
the other hand, fraction 5 could also be an important contributor
to the observed extract anti-inflammatory activity, considering
both its high yield from extract and its activity at higher
concentration.
Rosmarinic acid, a polyphenol compound with known anti-
inflammatory and antioxidant activities (26, 27), was of interest
because of its presence in P. vulgaris ethanol extracts (16).
Fraction 5 of the ethanol extract from Ames 27664 showed
significant inhibition on both PGE2 and NO productions,
whereas it containedmost of theRA in the extract. This suggested
RAbeing a probable anti-inflammatory component inP. vulgaris
ethanol extracts. Pure RA treatment at the concentration that
occurred in P. vulgaris ethanol extract significantly inhibited
LPS-induced PGE2 and NO productions, although it did not
explain all of the extract’s activity as shown by the lower
inhibitory potency. This confirmed RA as one active com-
pound that partially accounted for the overall anti-inflammatory
effect of P. vulgaris ethanol extracts. This is in accordance
with the recently published study on human gingival fibroblasts
by Zdarilova et al., in which an aqueous ethanol extract of
P. vulgaris and the corresponding RA component inhibited
LPS-induced oxidative stress and expression of several pro-
inflammatory enzymes including iNOS (8). Compared to their
study, we had a lower abundance of RA content (1.73-3.88% of
dry matter weight vs 9.0%) in the extract, which likely resulted
from our using 95% ethanol for extraction instead of the 30%
ethanol they used. According to Chizzola et al., an aqueous
ethanol extract was more capable of concentrating flavonoids
in Thymus vulgaris (28), which is likely the same case for
P. vulgaris and may explain the lower RA in our extracts. The
main reason that we used 95% ethanol was to minimize endotox-
in extraction. Although our extract was not designed to enrich
RA content, it was intriguing to see the RA effect at the extracted
concentration. To see whether additional RA can further pro-
mote the extract activity, we supplemented the extracts with
additional RA. As we expected, the RA-enriched extracts ex-
hibited a stronger inhibition of the LPS-induced inflamma-
tory response. We used two-way ANOVA with block to assess
whether there was interaction between RA and other com-
ponents in the extracts. No interaction was found (p = 0.85),
suggesting the RA effect was additive instead of synergetic when
it was added to the extracts. We also attempted to relate
RA concentration to activity potencies of various accessions,
Figure 5. Ethanol extracts from accessions Ames 27664, 27665, 27666, and 27748 (2007 harvest) with and without additional 2.67 μM rosmarinic acid were
applied to cells at 30μg/mL with and without 1 μg/mL LPS induction. RAwas also administrated alone at the same concentration. Both PGE2 (A) and NO (B)
productions are shown as percentage of mediaþ DMSO vehicle control as mean( SEM (N = 3). The 100% levels of PGE2 and NO production were 2.92(
0.18 ng/mL and 14.4( 0.96 μM, respectively. Statistically significant differences compared to vehicle control are marked with asterisks (/, p < 0.05; //, p <
0.01). Comparison was also made between extracts and extracts þ RA, as shown on top of the bars. Quercetin was used as a positive control at 10 μM
concentration. No difference was found in PGE2 and NO production without LPS stimulation among treatments, which is not shown.
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but the resulting Pearson correlation coefficient was not sig-
nificant for either PGE2 or NO inhibition (r = 0.42 and
p=0.22 for PGE2; r=-0.26 and p=0.4652 forNO). This ana-
lysis, together with the observation that the Ames 27664 extract
from the 2007 harvest had stronger activity but lower RA
concentration compared to that from 2008 and the most active
fraction 3 did not have the most RA, further predicted the
existence of anti-inflammatory component(s) other than RA in
these P. vulgaris ethanol extracts.
Ursolic acid is a known triterpene component in P. vulgaris
plantmaterial (18). UA concentration was 0.2 μMin 30 μg/mLof
the Ames 27664 ethanol extracts, far below the threshold for
significant anti-inflammatory effect reported by Ryu et al. (10).
This UA abundance was comparable to the results reported by
Lee et al. that showed UA accounted for 0.05-0.2% of dry
matter weight of ethanol extracts of 15 different P. vulgaris
market samples (29).We did not detectUA in any of the fractions
we studied. Despite the low abundance in the extracts, we
examined the effect of pure UA compound on LPS-induced
PGE2 and NO production by RAW 264.7 macrophages and
did not see any effect at up to 1 μM concentration (data not
shown). This ruled out UA as an independent active component
of P. vulgaris. We have been using UA as positive control in
cytotoxicity assay at 30 μM, but its cytotoxicity effect in the
extracts we used is improbable due to the extremely low concen-
tration.
COX-2 protein expression was significantly inhibited by
P. vulgaris ethanol extracts and pure RA, whereas iNOS protein
expression was only slightly attenuated by the extracts but not
RA. At the same time, COX-1 protein expression was not
affected. This evidence suggests inhibition exists at the transcrip-
tional level, possibly through NF-κB signaling pathways. It is
likely that there could be compounds other than RA in the
extracts inhibiting the expression and/or the activity of the two
critical enzymes in inflammation.
Although this study provides evidence for anti-inflamma-
tory activity of P. vulgaris in this well-defined mouse macro-
phage model, additional research is required to demonstrate
that these observations are relevant to human health and to
demonstrate that P. vulgaris affects macrophages in vivo. For
example, studies of bioavailability and long-term low-dose effects
in vivo are needed, especially because only relatively high con-
centrations of P. vulgaris extract showed significant activity. For
rosmarinic acid, bioavailability has been studied in a pigmodel by
Jirovsky et al., who showed that after 91 days of feedingmethanol
extract of P. vulgaris, RA and RA metabolites (caffeic acid, etc.)
were found in plasma at >0.08 μM (30). Notably, this is
considerably lower than the 2.67 μM dose we used. Therefore,
our study indicated the potential anti-inflammatory activity of
P. vulgaris but still awaits further investigation on its long-term in
vivo impact.
In summary, ethanol extracts of P. vulgaris inhibited LPS-
induced PGE2 and NO production in RAW 264.7 mouse
macrophage cells. This activity was dose-dependent and varied
among accessions and harvests. Rosmarinic acid, a poly-
phenol component of P. vulgaris ethanol extracts, showed
independent anti-inflammatory activity when applied to cells
at the same concentration as in the ethanol extract. However,
RA could only partially explain the overall activity of the ex-
tract. Ethanol extracts from P. vulgaris attenuated both COX-2
Figure 6. Treatments of controls and extracts or RA pure compoundwere applied to RAW264.7macrophages with or without LPS induction.MediaþDMSO
vehicle control was also used alone without induction. (A) shows a block of examples of COX-2 and iNOS protein expression level identified with Western
blotting. Constitutively expressed COX-1 expression was used as reference. (B) demonstrates COX-2 and iNOS protein abundance quantified as arbitrary
densities and showed as percentage of mediaþ DMSO vehicle control in mean( SEM (N = 4). Values with statistically significant differences are denoted
with different letters (a < b < c < d < e; p < 0.05). Quercetin positive control was used at 100 μM concentration.
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and iNOS protein expression, whereas pure RA demon-
strated inhibition on only COX-2. Further active compo-
nent identification and bioavailability studies will help reveal
more about P. vulgaris as an anti-inflammatory dietary supple-
ment.
ABBREVIATIONS USED
RA, rosmarinic acid; UA, ursolic acid; PGE2, prostaglan-
din E2; NO, nitric oxide; TLR4, toll-like receptor 4; COX-2,
cyclooxygenase-2; iNOS, nitric oxide synthase; NF-κB, nuclear
factor-κB.
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